Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Bolt Biotherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −3 vs. Q4 2022
- Shares held
- 23.3M
- +2.70M (+13.1%) vs. Q4 2022
- Total value
- $32.4M
- +$5.63M (+21.0%) vs. Q4 2022
- New holders
- 4
- 13 more added
- Sold out
- 7
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 3,871,291 | $5.38M | 0.40% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,838,445 | $3.95M | 0.00% | +86,283+3.1% | Added |
| Sofinnova Investments, Inc. | 2,754,437 | $3.83M | 0.26% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.63M | 1.08% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,627,553 | $2.26M | 0.34% | +1,227,553+306.9% | Added |
| OrbiMed Advisors LLC | 1,541,000 | $2.14M | 0.04% | +769,941+99.9% | Added |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.62M | 1.10% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,115,110 | $1.55M | 0.30% | −34,890−3.0% | Reduced |
| Samsara BioCapital, LLC | 1,049,153 | $1.46M | 0.30% | 00.0% | Unchanged |
| Vanguard Group Inc | 928,276 | $1.29M | 0.00% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $1.00M | 0.09% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 500,000 | $695.0K | 0.00% | +500,000 | New |
| Renaissance Technologies LLC | 456,739 | $635.0K | 0.00% | +15,200+3.4% | Added |
| Hawkeye Capital Management, LLC | 415,039 | $576.9K | 0.97% | 00.0% | Unchanged |
| Morgan Stanley | 306,402 | $425.9K | 0.00% | +271,519+778.4% | Added |
| Goldman Sachs Group Inc | 283,085 | $393.5K | 0.00% | +570.0% | Added |
| BlackRock Inc. | 274,430 | $381.5K | 0.00% | +1,317+0.5% | Added |
| Millennium Management LLC | 245,411 | $341.0K | 0.00% | +2,010+0.8% | Added |
| Assenagon Asset Management S.A. | 225,816 | $313.9K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 189,306 | $263.0K | 0.00% | +169,398+850.9% | Added |
| Geode Capital Management, LLC | 177,992 | $247.4K | 0.00% | +23,916+15.5% | Added |
| Velan Capital Investment Management LP | 140,000 | $194.6K | 0.17% | +140,000 | New |
| Privium Fund Management (UK) Ltd | 116,516 | $150.3K | 0.12% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 97,835 | $136.0K | 0.04% | 00.0% | Unchanged |
| FMR LLC | 78,433 | $109.0K | 0.00% | −60.0% | Reduced |
| Bridgeway Capital Management, LLC | 75,200 | $104.5K | 0.00% | −112,400−59.9% | Reduced |
| State Street Corp | 48,737 | $67.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 31,182 | $43.3K | 0.00% | −1,097−3.4% | Reduced |
| Bailard, Inc. | 28,500 | $39.6K | 0.00% | +28,500 | New |
| Man Group plc | – | $35.3K | 0.00% | – | – |
| Charles Schwab Investment Management Inc | 24,712 | $34.4K | 0.00% | +24,712 | New |
| Prudential Financial Inc | 24,400 | $33.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 20,120 | $28.0K | 0.00% | −187−0.9% | Reduced |
| Bank of New York Mellon Corp | 12,629 | $17.6K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 11,780 | $16.4K | 0.00% | +10,982+1,376.2% | Added |
| Federated Hermes, Inc. | 3,739 | $5.20K | 0.00% | −290−7.2% | Reduced |
| Tower Research Capital LLC (TRC) | 3,972 | $5.00K | 0.00% | +1,755+79.2% | Added |
| Northwestern Mutual Wealth Management Co | 400 | $556 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 151 | $210 | 0.00% | +2+1.3% | Added |
| Barclays PLC | 147 | $204 | 0.00% | −1,528−91.2% | Reduced |
| Salem Investment Counselors Inc | 40 | $56 | 0.00% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −280,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −40,195−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −31,172−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −28,507−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −14,014−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |